Australia In Vivo Cro Market Size & Outlook, 2025-2030
The in vivo cro market in Australia is expected to reach a projected revenue of US$ 106.3 million by 2030. A compound annual growth rate of 9.1% is expected of Australia in vivo cro market from 2025 to 2030.
Revenue, 2024 (US$M)
$62.3
Forecast, 2030 (US$M)
$106.3
CAGR, 2025 - 2030
9.1%
Report Coverage
Australia
Related Markets
Australia in vivo cro market highlights
- The Australia in vivo cro market generated a revenue of USD 62.3 million in 2024 and is expected to reach USD 106.3 million by 2030.
- The Australia market is expected to grow at a CAGR of 9.1% from 2025 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2024.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2024 | USD 62.3 million |
| Market revenue in 2030 | USD 106.3 million |
| Growth rate | 9.1% (CAGR from 2025 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Australia accounted for 1.3% of the global in vivo cro market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 386.6 million by 2030.
Small molecule was the largest segment with a revenue share of 68.38% in 2024. Horizon Databook has segmented the Australia in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
The Department of Health and industry stakeholders are collaborating to improve Australia’s clinical research and trial environment. The initiatives include receiving funding support from the Medical Research Future Fund to develop drug discovery centers, benefitting from favorable R&D tax incentives, and implementing streamlined regulatory pathways. These factors are expected to drive Australia’s in vivo CRO market during the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In vivo cro market segmentation & scope
Others
Others
Others
Others
Others
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SMO-Group | View profile | 101-250 | Kiev, Kyyivs'ka Oblast', Ukraine, Europe | https://www.smo-group.com/ |
| Biocytogen | View profile | 1001-5000 | Daxing, Beijing, China, Asia | https://biocytogen.com |
| PsychoGenics | View profile | 101-250 | Paramus, New Jersey, United States, North America | http://psychogenics.com |
| GemPharmatech | View profile | 1001-5000 | Nanjing, Jiangsu, China, Asia | http://www.gempharmatech.com/ |
| Janvier Labs | View profile | 251-500 | Le Genest, Pays de la Loire, France, Europe | https://janvier-labs.com |
| Taconic Biosciences | View profile | 501-1000 | Hudson, New York, United States, North America | http://www.taconic.com |
| JSR Corp | View profile | 7994 | 1-9-2 Higashi-Shimbashi, Shiodome Sumitomo Building, 22nd Floor, Minato-ku, Tokyo, Japan, 105-8640 | http://www.jsr.co.jp |
| Evotec SE | View profile | 5055 | Essener Bogen 7, Manfred Eigen Campus, Hamburg, Germany, 22419 | https://www.evotec.com |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Australia Large Molecule - In Vivo Cro Market, 2024 - 2030 (US$M)
Australia In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
